ArticleBMC genomics2026
Global phylogenomics of Bordetella pertussis ST2 reveals regional heterogeneity in China and lineage-specific genome evolution.
Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundBordetella pertussis sequence type 2 (ST2) is widely detected in China and in public genome datasets, yet the evolutionary relationships, dissemination patterns, and genomic features that distinguish its major lineages have not been systematically characterized.
resultsIn this study, we conducted a comprehensive genomic analysis of 580 ST2 genomes from 24 countries between 1942 and 2024, integrating 46 newly sequenced clinical isolates from Wenzhou, China. Phylogenetic reconstruction showed that the Wenzhou isolates were not homogeneous but comprised two distinct clades, including a dominant macrolide-resistant ptxP1-associated lineage and a smaller ptxP3-associated lineage. At the global scale, the ST2 population resolved into two major clades and three subclades; the dominant ptxP1-associated Wenzhou lineage was assigned to subclade I, whereas the smaller ptxP3-associated Wenzhou lineage belonged to global clade II, with one isolate placed in subclade III. Two China-enriched subclades were strongly associated with 23S rRNA A2047G mutations, whereas a geographically widespread subclade lacked this determinant. Chinese isolates were distributed across multiple phylogenetic positions, supporting repeated introductions followed by local expansion. Comparative analyses further revealed lineage-specific differences in detected insertion sequence (IS) elements and pseudogene accumulation. IS481 was the predominant IS family, and intergenic insertions were more common than intragenic events across lineages. Clade-specific SNPs and stable pseudogene patterns together indicated partially distinct adaptive trajectories among ST2 clades.
conclusionsThese findings define the local and global population structure of ST2, highlight marked regional heterogeneity in contemporary Chinese pertussis, and show that ongoing diversification of this lineage is shaped by both geographic spread and lineage-specific genome evolution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.